198 results
Page 2 of 10
8-K
EX-99.1
6gvzw4
14 Dec 23
Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
4:05pm
8-K
EX-99.1
70freupplbwebwb0qk36
15 Nov 23
Bio-path Holdings Reports Third Quarter 2023 Financial Results
7:30am
DEFA14A
dv846an9hp zon
27 Oct 23
Additional proxy soliciting materials
4:35pm
8-K
EX-99.1
0i3my3y7d7 ys3
24 Oct 23
Regulation FD Disclosure
4:30pm
8-K
EX-99.1
4ol51fc
15 Aug 23
Bio-path Holdings Reports Second Quarter 2023 Financial Results
7:10am
8-K
EX-10.2
d9hq x5yapwm
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
424B4
ft9pe64z5z6q
7 Aug 23
Prospectus supplement with pricing info
7:16am
8-K
EX-99.1
p5wypbqw4vtxbm9c62z
12 May 23
Bio-path Holdings Reports First Quarter 2023 Financial Results
7:10am